Literature DB >> 16972086

Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications.

Lequn Li1, Vassiliki A Boussiotis.   

Abstract

Immunologic tolerance is a state of unresponsiveness that is specific for a particular antigen. The immune system has an extraordinary potential for making T cell and B cell that recognize and neutralize any chemical entity and microbe entering the body. Certainly, some of these T cells and B cells recognize self-components; therefore, cellular mechanisms have evolved to control the activity of these self-reactive cells and achieve immunological self-tolerance. The most important in vivo biological significance of mechanisms regulating self-tolerance is to prevent the immune system from mounting an attack against the host's own tissues resulting in autoimmunity. This review summarizes recent developments in our understanding of T-helper cell tolerance and discusses how the new findings can be exploited to prevent and treat autoimmune diseases, allergy, cancer, and chronic infection, or establish donor-specific transplantation tolerance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16972086     DOI: 10.1007/s00109-006-0098-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  103 in total

Review 1.  Antigen receptor selection by editing or downregulation of V(D)J recombination.

Authors:  David Nemazee; Kristin A Hogquist
Journal:  Curr Opin Immunol       Date:  2003-04       Impact factor: 7.486

Review 2.  Immunoregulation of dendritic cells.

Authors:  Mark A Wallet; Pradip Sen; Roland Tisch
Journal:  Clin Med Res       Date:  2005-08

3.  Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo.

Authors:  Lequn Li; Rebecca J Greenwald; Esther M Lafuente; Dimitrios Tzachanis; Alla Berezovskaya; Gordon J Freeman; Arlene H Sharpe; Vassiliki A Boussiotis
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

4.  Transplantation of anergic histoincompatible bone marrow allografts.

Authors:  E C Guinan; V A Boussiotis; D Neuberg; L L Brennan; N Hirano; L M Nadler; J G Gribben
Journal:  N Engl J Med       Date:  1999-06-03       Impact factor: 91.245

5.  Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Authors:  D Tzachanis; G J Freeman; N Hirano; A A van Puijenbroek; M W Delfs; A Berezovskaya; L M Nadler; V A Boussiotis
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

6.  CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.

Authors:  E A Tivol; S D Boyd; S McKeon; F Borriello; P Nickerson; T B Strom; A H Sharpe
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

7.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

8.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

9.  Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism.

Authors:  Bruce R Blazar; Beatriz M Carreno; Angela Panoskaltsis-Mortari; Laura Carter; Yoshiko Iwai; Hideo Yagita; Hiroyuki Nishimura; Patricia A Taylor
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

10.  Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis.

Authors:  Franck Dequiedt; Johan Van Lint; Emily Lecomte; Viktor Van Duppen; Thomas Seufferlein; Jackie R Vandenheede; Ruddy Wattiez; Richard Kettmann
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307

View more
  9 in total

Review 1.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

2.  Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.

Authors:  Nikolaos Patsoukis; Julia Brown; Victoria Petkova; Fang Liu; Lequn Li; Vassiliki A Boussiotis
Journal:  Sci Signal       Date:  2012-06-26       Impact factor: 8.192

3.  PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.

Authors:  Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

Review 4.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

Review 5.  Vaccines for multiple sclerosis: progress to date.

Authors:  Jorge Correale; Mauricio Farez; Wendy Gilmore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Antibody association with HER-2/neu-targeted vaccine enhances CD8 T cell responses in mice through Fc-mediated activation of DCs.

Authors:  Peter S Kim; Todd D Armstrong; Hong Song; Matthew E Wolpoe; Vivian Weiss; Elizabeth A Manning; Lan Qing Huang; Satoshi Murata; George Sgouros; Leisha A Emens; R Todd Reilly; Elizabeth M Jaffee
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

7.  Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells.

Authors:  Zohreh Tatari-Calderone; Milica Stojakovic; Ramita Dewan; Gama Le Bouder; Dragana Jankovic; Stanislav Vukmanovic
Journal:  BMC Immunol       Date:  2012-02-09       Impact factor: 3.615

8.  The mannosylated extracellular domain of Her2/neu produced in P. pastoris induces protective antitumor immunity.

Authors:  Alexios Dimitriadis; Chrysanthi Gontinou; Constantin N Baxevanis; Avgi Mamalaki
Journal:  BMC Cancer       Date:  2009-10-30       Impact factor: 4.430

9.  Composite tissue allotransplantation immunology.

Authors:  Seok Chan Eun
Journal:  Arch Plast Surg       Date:  2013-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.